Sympathetic Mechanisms in Obesity-Crossover Design

NCT05312892 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Hypertension

Interventions

DRUG: Amlodipine
DRUG: Moxonidine
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center